David T. MacPherson - Concepedia

Author

David T. MacPherson

Also Known As

D. MacPherson, D. T. MACPHERSON, D. T. Macpherson, D.T. MacPherson, DAVID T. MACPHERSON, David MacPherson, David T MacPherson, David T. MacPherson, David T. Macpherson

Publications

912

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University of Leeds Molecular Discovery (United Kingdom)University of East Anglia Sheffield City Council

About

David T. MacPherson is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, chemistry, and organic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	289
2	Natural Sciences	6	6	230
3	Engineering	5	5	186
4	Biochemistry	5	5	202
5	Biomolecular Engineering	3	3	143

David T. MacPherson

Publications

856

Citations

H-Index

Page 1

	Year	Citations
Pd-Catalyzed Cycloisomerization to 1,2- Dialkylidenecycloalkanes. 1 Barry M. Trost, Gerald J. Tanoury, Mark Lautens, Journal of the American Chemical Society Pd-catalyzed CycloisomerizationMolecular SciencesHeterocyclicChemical AnalysisCross-coupling Reaction	1994	180
[4 + 3] Cycloaddition of a trimethylenemethane fragment. An approach to polyhydroazulenes Barry M. Trost, David T. MacPherson Journal of the American Chemical Society Molecular SciencesEngineeringHeterocyclicChemical AnalysisAltmetric Attention Score	1987	99
GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility Gareth J. Sanger, Susan M. Westaway, Ashley Barnes, Neurogastroenterology & Motility Gastrointestinal PharmacologyGastroenterologyPharmacotherapyExperimental PharmacologyGastrointestinal Peptide Hormone	2009	77
BACE-1 inhibitors part 3: Identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells Paul Beswick, Nicolas Charrier, Brian Clarke, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceBiochemistryNanomolar PotencyMedicine	2008	57
BACE-1 inhibitors part 2: Identification of hydroxy ethylamines (HEAs) with reduced peptidic character Brian Clarke, Emmanuel H. Demont, Colin Dingwall, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryBiochemistryMedicineNatural Sciences	2008	56
Pictet–Spengler/Palladium Catalyzed Allenylation and Carbonylation Processes Ronald Grigg, William S. MacLachlan, David T. MacPherson, Tetrahedron Pictet–spengler/palladium Catalyzed AllenylationOrganometallic CatalysisCatalysisChemistryCatalytic Synthesis	2000	54
BACE-1 inhibitors Part 1: Identification of novel hydroxy ethylamines (HEAs) Brian Clarke, Emmanuel H. Demont, Colin Dingwall, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceBiochemistryMedicineNatural Sciences	2008	47
Solid phase sequential 1,3-dipolar cycloaddition–Pictet–Spengler reactions H. Ali Döndaş, Ronald Grigg, William S. MacLachlan, Tetrahedron Letters Organic ChemistryHeterocyclicChemistry	2000	43
Discovery of <i>N</i>-(3-Fluorophenyl)-1-[(4-([(3<i>S</i>)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the First Small Molecule Motilin Receptor Agonist Clinical Candidate Susan M. Westaway, Samantha L. Brown, Stephen C. M. Fell, Journal of Medicinal Chemistry Drug TargetFurther ProfilingPeptide SciencePharmacotherapyHuman Native Tissue	2009	29
Total synthesis of cyclopentanoid natural products Alan T. Hewson, David T. MacPherson Journal of the Chemical Society Perkin Transactions 1 Diversity Oriented SynthesisDiketo EsterDerivativesBioorganic ChemistryEngineering	1985	28

Page 1